These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11220758)

  • 41. Trichomonas vaginalis: analysis of a heat-inducible member of the cytosolic heat-shock-protein 70 multigene family.
    Davis-Hayman SR; Shah PH; Finley RW; Lushbaugh WB; Meade JC
    Parasitol Res; 2000 Jul; 86(7):608-12. PubMed ID: 10935914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [RAPD analysis on different isolates of Trichomonas vaginalis].
    Yuan LJ; Gao XZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Apr; 22(2):90-3. PubMed ID: 15281450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trichomoniasis: evaluation to execution.
    Harp DF; Chowdhury I
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Premature with trichomoniasis: report of one case.
    Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
    Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of Trichomonas vaginalis isolates from the Philippines.
    Rivera WL; Ong VA; Masalunga MC
    Parasitol Res; 2009 Dec; 106(1):105-10. PubMed ID: 19779740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Geographic variation among isolates of Trichomonas vaginalis: demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique.
    Krieger JN; Holmes KK; Spence MR; Rein MF; McCormack WM; Tam MR
    J Infect Dis; 1985 Nov; 152(5):979-84. PubMed ID: 2413147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
    Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity.
    Sariego I; Monzote L; Rojas L
    Curr Clin Pharmacol; 2014; 9(3):283-7. PubMed ID: 23173972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic diversity of Trichomonas vaginalis clinical isolates from Henan province in central China.
    Mao M; Liu HL
    Pathog Glob Health; 2015 Jul; 109(5):242-6. PubMed ID: 26103990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
    Wright JM; Dunn LA; Kazimierczuk Z; Burgess AG; Krauer KG; Upcroft P; Upcroft JA
    Parasitol Res; 2010 Sep; 107(4):847-53. PubMed ID: 20532912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Murine pathogenicity of Trichomonas vaginalis & its susceptibility to metronidazole.
    Jayarao P; Gogate A; Deodhar L
    Indian J Med Res; 1991 Mar; 93():90-4. PubMed ID: 1855825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
    Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
    Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of zymodeme patterns, virulence & drug sensitivity of Trichomonas vaginalis isolates from women.
    Vohra H; Sharma P; Sofi BA; Gupta I; Ganguly NK; Mahajan RC; Malla N
    Indian J Med Res; 1991 Jan; 93():37-9. PubMed ID: 2022400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis.
    Rasoloson D; Vanacova S; Tomkova E; Razga J; Hrdy I; Tachezy J; Kulda J
    Microbiology (Reading); 2002 Aug; 148(Pt 8):2467-2477. PubMed ID: 12177340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.
    Mallo N; Lamas J; Leiro JM
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2476-84. PubMed ID: 23478970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterisation of Trichomonas vaginalis isolates in Southwest Turkey with multilocus sequence typing and genetic structure analysis in relation to different countries.
    Malatyali E; Guclu O; Yildiz I; Bozdogan B; Ertug S; Ertabaklar H
    Infect Genet Evol; 2020 Oct; 84():104459. PubMed ID: 32681998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mycoplasma hominis symbiosis and Trichomonas vaginalis metronidazole resistance].
    Wang PJ; Xie CB
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):210-3. PubMed ID: 23072138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.